NJ DOBI Bulletin 2004-26
2001 Commissioner's Standard Ordinary Mortality Table for Use in Determining Minimum Reserve Liabilities and Non-forfeiture Benefits
State of New Jersey
DEPARTMENT OF BANKING AND INSURANCE
PO BOX 325
TRENTON, NJ 08625-0325
RICHARD J. CODEY
HOLLY C. BAKKE
Acting Governor
TEL (609) 292-5360
Commissioner
Visit us on the Web at www.njdobi.org
New Jersey is an Equal Opportunity Employer • Printed on Recycled Paper and Recyclable
BULLETIN NO. 04-26
TO:
ALL LIFE INSURANCE COMPANIES AND FRATERNAL
BENEFIT ORGANIZATIONS AUTHORIZED TO ISSUE
LIFE INSURANCE IN NEW JERSEY
FROM:
HOLLY C. BAKKE, COMMISSIONER
RE:
2001
COMMISSIONER’S
STANDARD
ORDINARY
MORTALITY TABLE FOR USE IN DETERMINING
MINIMUM
RESERVE
LIABILITIES
AND
NON-
FORFEITURE BENEFITS
The purpose of this Bulletin is to provide guidance to companies with
respect to their submission of individual life forms in order to implement the
use of the 2001 CSO Mortality Table pursuant to N.J.A.C. 11:4-27 et.seq.
(“2001 CSO Mortality Table” includes all Appendicies to N.J.A.C. 11:4-27.)
The mortality table to be used for minimum reserve liabilities and non-
forfeiture benefits is determined as of the issue date of the life insurance
policy. N.J.A.C. 11:4-27 allows for the use of the 2001 CSO mortality table
at the option of the company, as early as January 1, 2005. The company may
elect to introduce the new table on a plan by plan basis or uniformly for all
life insurance products. If a company elects to use the 2001 CSO Table, it
must do so for both valuation and non-forfeiture.
Use of the 2001 CSO Table will be required for all life insurance
policies effective on January 1, 2009 and thereafter.
Upon the approval or acknowledgement by the Department of any
individual life form based upon the 2001 CSO Table, the company must
discontinue the use of any comparable form for the 1980 CSO Table.
s to use the 2001 CSO Table, it
must do so for both valuation and non-forfeiture.
Use of the 2001 CSO Table will be required for all life insurance
policies effective on January 1, 2009 and thereafter.
Upon the approval or acknowledgement by the Department of any
individual life form based upon the 2001 CSO Table, the company must
discontinue the use of any comparable form for the 1980 CSO Table.
2
N.J.A.C. 11:4-24.4 sets standards for the use of smoker/non-smoker
mortality tables in the case of juvenile insureds (for which the smoker/non-
smoker table does not extend to all juvenile ages). Although "Smoker and
nonsmoker mortality tables" as defined at N.J.A.C. 11:4-24.2 does not
include the 2001 CSO Table, companies adopting the use of 2001 CSO
Smoker/Non-Smoker Tables for one or more plans should follow the
standards of N.J.A.C. 11:4-24.4 for juvenile issues for these plans. The
Department intends to modify its rules to make N.J.A.C. 11:4-24.4
specifically applicable to the 2001 CSO Smoker/Non-Smoker tables.
Companies may immediately begin submitting new individual life
form filings based upon the new mortality table to the Department for
approval or acknowledgement for use on or after January 1, 2005.
The Department will review such filings in accordance with the
following normal time frames: 60 days for new submissions and 30 days for
re-submissions.
A company may submit a form filing to amend a previously approved
individual life form which is based upon the 1980 CSO tables by submitting:
1) revised policy pages (with new distinct identifying form numbers); or 2)
an amendment; or 3) an endorsement to modify the basis of computation and
all related tables of values. Regardless of which submission is made, in all
cases the submission must be accompanied by an updated actuarial
memorandum
a previously approved
individual life form which is based upon the 1980 CSO tables by submitting:
1) revised policy pages (with new distinct identifying form numbers); or 2)
an amendment; or 3) an endorsement to modify the basis of computation and
all related tables of values. Regardless of which submission is made, in all
cases the submission must be accompanied by an updated actuarial
memorandum.
The Department will review such form filing submissions on an
expedited basis if: 1) the only change to the form is the change in the
mortality table and related values; 2) the submission contains a cover letter
with a specific statement to this effect; and 3) the submission contains a
black-lined version of the approved form indicating changes. An expedited
review will not be available for submissions that do not meet all of these
conditions or that contain revisions in addition to the change in mortality
table/related values.
Filings not reviewed on an expedited basis shall be reviewed in
accordance with the Department’s normal time frames as stated above.
Companies may also amend form filings that are under current review
by the Department, or that are otherwise in a pending status, to implement the
new table(s). To receive expedited treatment, the amendment to the filing
3
must include an updated actuarial memorandum that addresses the 2001 CSO
Table, if not previously submitted, and satisfy all of the three enumerated
conditions.
This Bulletin provides guidance on the most likely situations for
companies wishing to make changes to their products to introduce the 2001
Mortality Table. It is not possible to address every possible variation in
product design or filing status in this Bulletin. Companies are reminded that
all form submissions shall be made in accordance with N.J.A.C. 11:4-40 et.
seq.
Questions regarding this Bulletin may be faxed to 609-633-0527.
Questions related to form filing or content aspects may also be directed to The
Office of Life and Health at 609-292-5427, extension 50340
to address every possible variation in
product design or filing status in this Bulletin. Companies are reminded that
all form submissions shall be made in accordance with N.J.A.C. 11:4-40 et.
seq.
Questions regarding this Bulletin may be faxed to 609-633-0527.
Questions related to form filing or content aspects may also be directed to The
Office of Life and Health at 609-292-5427, extension 50340.
Questions may also be submitted by mail to:
Office of Life and Health
New Jersey Department of Banking and Insurance
20 West State Street
PO Box 325
Trenton, NJ 08625-0325
12/8/04
/s/ Holly C. Bakke
Date
Holly C. Bakke, Commissioner
Inord/jdy04-01cso